BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6138775)

  • 1. Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat.
    Ferrer JM; Sanguinetti AM; Vives F; Mora F
    Pharmacol Biochem Behav; 1983 Aug; 19(2):211-7. PubMed ID: 6138775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
    Kamijo N; Nagao T; Ono H
    Neuropharmacology; 1993 Aug; 32(8):777-83. PubMed ID: 8105410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial self-stimulation in orbitofrontal cortex and caudate nucleus of rhesus monkey: effects of apomorphine, pimozide, and spiroperidol.
    Phillips AG; Mora F; Rolls ET
    Psychopharmacology (Berl); 1979 Mar; 62(1):79-82. PubMed ID: 108751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal cortex and neostriatum self-stimulation in the rat: differential effects produced by apomorphine.
    Mora F; Phillips AG; Koolhaas JM; Rolls ET
    Brain Res Bull; 1976; 1(5):421-4. PubMed ID: 1009443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures.
    Warter JM; Vergnes M; Depaulis A; Tranchant C; Rumbach L; Micheletti G; Marescaux C
    Neuropharmacology; 1988 Mar; 27(3):269-74. PubMed ID: 2836751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
    Karlsson G; Jaton AL; Vigouret JM
    Neurosci Lett; 1988 May; 88(1):69-74. PubMed ID: 2969468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
    de Belleroche J; Gardiner IM
    J Neural Transm; 1983; 58(3-4):153-68. PubMed ID: 6141217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor subtypes and formalin test analgesia.
    Morgan MJ; Franklin KB
    Pharmacol Biochem Behav; 1991 Oct; 40(2):317-22. PubMed ID: 1687167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite influences of dopaminergic receptor subtypes on penile erection.
    Zarrindast MR; Shokravi S; Samini M
    Gen Pharmacol; 1992 Jul; 23(4):671-5. PubMed ID: 1356874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):165-76. PubMed ID: 6143675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices.
    RĂ©taux S; Besson MJ; Penit-Soria J
    Neuroscience; 1991; 42(1):61-71. PubMed ID: 1677746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.
    Bagetta G; De Sarro G; Priolo E; Nisticò G
    Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of selective dopamine receptor agonists and antagonists on body temperature in rats.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1987 Jan; 133(3):243-7. PubMed ID: 2951265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions.
    Passetti F; Levita L; Robbins TW
    Behav Brain Res; 2003 Jan; 138(1):59-69. PubMed ID: 12493630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DA-1- and DA-2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission.
    Hietala J
    J Auton Pharmacol; 1988 Dec; 8(4):297-302. PubMed ID: 2855331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.